Literature DB >> 14969054

Work disability in early rheumatoid arthritis.

T Sokka1.   

Abstract

Patients with rheumatoid arthritis (RA) are at risk of work disability from the very start of their symptoms. Prospective cohorts including patients with early RA show that 20-30% become permanently work disabled during the first 2-3 years of the disease. Risk factors for early work disability include a physically demanding job, older age, and lower educational level, as well as the level of functional disability in daily activities. Work disability accounts for a major fraction of the costs of RA both to the patient and to society. Improved work disability outcomes in RA may require attention to social, economic, and political issues, and broader physician and public education concerning RA, in addition to improved medical management of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 14969054

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  44 in total

1.  Rheumatoid arthritis: prevalence, economics, and implications for payers and purchasers.

Authors:  Lola Butcher
Journal:  Biotechnol Healthc       Date:  2008-07

2.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

3.  Association between activity and genotypes of paraoxonase1 L55M (rs854560) increases the disease activity of rheumatoid arthritis through oxidative stress.

Authors:  Maryam Tanhapour; Shiva Shahmohamadnejad; Asad Vaisi-Raygani; Amir Kiani; Yadola Shakiba; Zohreh Rahimi; Fariborz Bahrehmand; Ebrahim Shakiba; Ali-Akbar Vaisi-Raygani; Reza Alibakhshi; Atefeh Eivazi; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2018-12-01       Impact factor: 2.316

4.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

5.  Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries.

Authors:  Kalle Mattila; Frank Buttgereit; Risto Tuominen
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

6.  Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.

Authors:  Rhonda Greenapple
Journal:  Am Health Drug Benefits       Date:  2012-03

7.  Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Pantelis Panopalis; Jinoos Yazdany; Laura Julian; Patricia Katz; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-02-15

8.  Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education.

Authors:  R Dray-Spira; A Gueguen; F Lert
Journal:  Occup Environ Med       Date:  2007-11-02       Impact factor: 4.402

9.  Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Theodore Pincus; Suzanne M M Verstappen; Amita Aggarwal; Rieke Alten; Daina Andersone; Humeira Badsha; Eva Baecklund; Miguel Belmonte; Jürgen Craig-Müller; Licia Maria Henrique da Mota; Alexander Dimic; Nihal A Fathi; Gianfranco Ferraccioli; Wataru Fukuda; Pál Géher; Feride Gogus; Najia Hajjaj-Hassouni; Hisham Hamoud; Glenn Haugeberg; Dan Henrohn; Kim Horslev-Petersen; Ruxandra Ionescu; Dmitry Karateew; Reet Kuuse; Ieda Maria Magalhaes Laurindo; Juris Lazovskis; Reijo Luukkainen; Ayman Mofti; Eithne Murphy; Ayako Nakajima; Omondi Oyoo; Sapan C Pandya; Christof Pohl; Denisa Predeteanu; Mjellma Rexhepi; Sylejman Rexhepi; Banwari Sharma; Eisuke Shono; Jean Sibilia; Stanislaw Sierakowski; Fotini N Skopouli; Sigita Stropuviene; Sergio Toloza; Ivo Valter; Anthony Woolf; Hisashi Yamanaka
Journal:  Arthritis Res Ther       Date:  2010-03-12       Impact factor: 5.156

Review 10.  Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.

Authors:  Barbara Muz; Moddasar N Khan; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-01-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.